Gastrointestinal Stromal Tumor Recurrence Presenting as a Small Bowel Obstruction: A Case Report

被引:0
作者
Neama, Dana A. [1 ]
Araibi, Sarah J. Al [1 ]
Alderazi, Amer E. [2 ]
Almahari, Sayed Ali I. [3 ]
Alawadhi, Abdulrahman M. [3 ]
机构
[1] Gen Surg, Salmaniya Med Complex, BHR, Manama, Bahrain
[2] Gen & Bariatr Surg, Salmaniya Med Complex, BHR, Manama, Bahrain
[3] Pathol & Lab Med, Salmaniya Med Complex, BHR, Manama, Bahrain
关键词
tyrosine kinase inhibitor; tki; small bowel obstruction; abdominal mass; gist; gastrointestinal stromal tumor; KIT; MANAGEMENT; MUTATIONS;
D O I
10.7759/cureus.33806
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the alimentary tract in adults. The most common site is the stomach, followed by the small intestine. The clinical presentation varies from an incidental finding in asymptomatic patients to a large palpable mass causing complications such as bowel obstruction or viscus perforation. The best imaging modality is a CT scan of the abdomen. Treatment is determined by the size and location of the GISTs. Surgical intervention is considered for resectable tumors, while tyrosine kinase inhibitor therapy is considered for irresectable, metastatic, or recurrent GISTs. In this case report, we present a 30-year-old female who is a known case of gastric GIST and liver metastases. She presented to the emergency department with intestinal obstruction secondary to a recurrent GIST abdominal mass and underwent emergency laparotomy for mass resection. Following surgery, the patient developed aspiration pneumonia, which was treated with proper antibiotics. She was discharged in stable clinical condition with a recommendation to start alternative tyrosine kinase therapy. GISTs are difficult to diagnose preoperatively, as most patients are asymptomatic, and they may present with complications, as in our case, a small bowel obstruction. A proper imaging modality will guide the physician toward the diagnosis, but the final diagnosis will be achieved by biopsy. The diagnosis may be challenging, as small bowel obstruction has many causes, although GISTs should be kept in mind as one of the deferential diagnoses.
引用
收藏
页数:7
相关论文
共 15 条
  • [1] Current clinical management of gastrointestinal stromal tumor
    Akahoshi, Kazuya
    Oya, Masafumi
    Koga, Tadashi
    Shiratsuchi, Yuki
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (26) : 2806 - 2817
  • [2] Gastrointestinal stromal tumor (GIST) recurrence following surgery: review of the clinical utility of imatinib treatment
    Deshaies, Isabelle
    Cherenfant, Jovenel
    Gusani, Niraj J.
    Jiang, Yixing
    Harvey, Harold A.
    Kimchi, Eric T.
    Kaifi, Jussuf T.
    Staveley-O'Carroll, Kevin F.
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 : 453 - 458
  • [3] Pancreatic gastrointestinal stromal tumor: A case report
    Elgeidie, Ahmed
    Abou El-Magd, El-Sayed
    Abu El-Maaty, Sara Raafat
    El-Hawary, Amira Kamal
    [J]. INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2016, 29 : 67 - 70
  • [4] Gerrish ST, 2008, OCHSNER J, V8, P197
  • [5] PDGFRA activating mutations in gastrointestinal stromal tumors
    Heinrich, MC
    Corless, CL
    Duensing, A
    McGreevey, L
    Chen, CJ
    Joseph, N
    Singer, S
    Griffith, DJ
    Haley, A
    Town, A
    Demetri, GD
    Fletcher, CDM
    Fletcher, JA
    [J]. SCIENCE, 2003, 299 (5607) : 708 - 710
  • [6] Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
    Hirota, S
    Isozaki, K
    Moriyama, Y
    Hashimoto, K
    Nishida, T
    Ishiguro, S
    Kawano, K
    Hanada, M
    Kurata, A
    Takeda, M
    Tunio, GM
    Matsuzawa, Y
    Kanakura, Y
    Shinomura, Y
    Kitamura, Y
    [J]. SCIENCE, 1998, 279 (5350) : 577 - 580
  • [7] Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations
    Janeway, Katherine A.
    Kim, Su Young
    Lodish, Maya
    Nose, Vania
    Rustin, Pierre
    Gaal, Jose
    Dahia, Patricia L. M.
    Liegl, Bernadette
    Ball, Evan R.
    Raygada, Margarita
    Lai, Angela H.
    Kelly, Lorna
    Hornick, Jason L.
    O'Sullivan, Maureen
    de Krijger, Ronald R.
    Dinjens, Winand N. M.
    Demetri, George D.
    Antonescu, Cristina R.
    Fletcher, Jonathan A.
    Helman, Lee
    Stratakis, Constantine A.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (01) : 314 - 318
  • [8] The management of metastatic GIST: current standard and investigational therapeutics
    Kelly, Ciara M.
    Sainz, Laura Gutierrez
    Chi, Ping
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [9] Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis
    Mearadji, Amir
    den Bakker, Michael A.
    van Geel, Albertus N.
    Eggermont, Alexander M. M.
    Sleijfer, Stefan
    Verweij, Jaap
    de Wilt, Johannes H. W.
    Verhoef, Cornelis
    [J]. ANTI-CANCER DRUGS, 2008, 19 (06) : 607 - 612
  • [10] KIT-negative gastrointestinal stromal tumors - Proof of concept and therapeutic implications
    Medeiros, F
    Corless, CL
    Duensing, A
    Hornick, JL
    Oliveira, AM
    Heinrich, MC
    Fletcher, JA
    Fletcher, CDM
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (07) : 889 - 894